Sochal, M.; Fichna, J.; Gabryelska, A.; Talar-Wojnarowska, R.; Białasiewicz, P.; Małecka-Wojciesko, E.
Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy. J. Clin. Med. 2021, 10, 4615.
https://doi.org/10.3390/jcm10194615
AMA Style
Sochal M, Fichna J, Gabryelska A, Talar-Wojnarowska R, Białasiewicz P, Małecka-Wojciesko E.
Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy. Journal of Clinical Medicine. 2021; 10(19):4615.
https://doi.org/10.3390/jcm10194615
Chicago/Turabian Style
Sochal, Marcin, Jakub Fichna, Agata Gabryelska, Renata Talar-Wojnarowska, Piotr Białasiewicz, and Ewa Małecka-Wojciesko.
2021. "Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy" Journal of Clinical Medicine 10, no. 19: 4615.
https://doi.org/10.3390/jcm10194615
APA Style
Sochal, M., Fichna, J., Gabryelska, A., Talar-Wojnarowska, R., Białasiewicz, P., & Małecka-Wojciesko, E.
(2021). Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy. Journal of Clinical Medicine, 10(19), 4615.
https://doi.org/10.3390/jcm10194615